Using Animal Models for Gender-Affirming Hormone Therapy

被引:3
|
作者
Aghi, Krisha [1 ]
Goetz, Teddy G. [2 ]
Pfau, Daniel R. [3 ,4 ,5 ]
Sun, Simon D. [6 ,7 ]
Guthman, Eartha Mae [7 ,8 ]
Roepke, Troy A. [9 ,10 ]
机构
[1] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA
[2] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA
[3] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Div Pediat Endocrinol Diabet & Metab, Ann Arbor, MI 48109 USA
[6] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA
[7] Ctr Appl Transgender Studies, Chicago, IL USA
[8] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08540 USA
[9] Rutgers State Univ, Sch Environm & Biol Sci, Dept Anim Sci, New Brunswick, NJ 08901 USA
[10] Rutgers State Univ, 84 Lipman Dr,Bartlett Hall, New Brunswick, NJ 08901 USA
关键词
gender identity; gender-affirming hormone therapy; steroids; estrogens; testosterone; animal models;
D O I
10.1210/jendso/bvad144
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have recently proposed experimental design guidelines and areas of study for preclinical rodent models of gender-affirming hormone therapy in neuroscience. These guidelines also apply to any field subject to the influences of gonadal steroid hormones, including metabolism and growth, cancer, and physiology. This perspective briefly describes our suggestions for these fields. Studying the effects of exogenous steroid hormones will have translational benefits for the community. We also discuss the need for equitable practices for cisgender scientists who wish to implement these guidelines and engage with the community. It is necessary that community-informed practices are implemented in preclinical research to maximize the benefit to transgender, nonbinary, and/or gender diverse (TNG) healthcare, which is currently in jeopardy in the United States, Europe, and across the globe.
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Changes in affect variability after starting gender-affirming hormone therapy
    Morssinkhof, Margot W. L.
    Schipper, Marijn
    Kreukels, Baudewijntje P. C.
    van der Tuuk, Karin
    den Heijer, Martin
    van den Heuvel, Odile A.
    Doyle, David Matthew
    Broekman, Birit F. P.
    PSYCHONEUROENDOCRINOLOGY, 2025, 175
  • [42] Gender-Affirming Hormone Therapy Spending and Use in the USA, 2013–2019
    Rishub K. Das
    Stacie B. Dusetzina
    Journal of General Internal Medicine, 2023, 38 : 260 - 262
  • [43] The Effect of Gender-Affirming Hormone Therapy on Serum Creatinine in Transgender Individuals
    Maheshwari, Arvind
    Dines, Virginia
    Saul, Dominik
    Nippoldt, Todd
    Kattah, Andrea
    Davidge-Pitts, Caroline
    ENDOCRINE PRACTICE, 2022, 28 (01) : 52 - 57
  • [44] Gender-affirming hormone therapy: An updated literature review with an eye on the future
    D'hoore, Laurens
    T'Sjoen, Guy
    JOURNAL OF INTERNAL MEDICINE, 2022, 291 (05) : 574 - 592
  • [45] The effect of gender-affirming hormone therapy on hair growth - A systematic review
    Tang, Gia
    Sinclair, Rodney
    Zajac, Jeffrey
    Cheung, Ada
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 : 49 - 49
  • [46] Venous Thromboembolism and Gender-Affirming Hormone Therapy: A Reappraisal of Risks and Benefits
    Dreijerink, Koen M. A.
    ENDOCRINE PRACTICE, 2023, 29 (04) : 301 - 302
  • [47] Venous Thromboembolism and Estrogen-Containing Gender-Affirming Hormone Therapy
    Dix, Caroline
    Moloney, Mollie
    Tran, Huyen A.
    McFadyen, James D.
    THROMBOSIS AND HAEMOSTASIS, 2024, 124 (05) : 387 - 398
  • [48] Gender-Affirming Hormone Therapy and Depressive Symptoms Among Transgender Adults
    Reisner, Sari L.
    Pletta, David R.
    Keuroghlian, Alex S.
    Mayer, Kenneth H.
    Deutsch, Madeline B.
    Potter, Jennifer
    Hughto, Jaclyn M. W.
    Harris, Alexander
    Radix, Asa E.
    JAMA NETWORK OPEN, 2025, 8 (03)
  • [49] Revisiting Injectable Estrogen Dosing Recommendations for Gender-Affirming Hormone Therapy
    Rothman, Micol S.
    Hamnvik, Ole-Petter R.
    Davidge-Pitts, Caroline
    Safer, Joshua D.
    Ariel, Danit
    Tangpricha, Vin
    Abramowitz, Jessica
    Soe, Kyaw
    Sarvaideo, Jenna
    Kelley, Carly
    Irwig, Michael S.
    Iwamoto, Sean J.
    TRANSGENDER HEALTH, 2024,
  • [50] Thrombosis Risk in Transgender Adolescents Receiving Gender-Affirming Hormone Therapy
    Mullins, Eric S.
    Geer, Rebecca
    Metcalf, Megan
    Piccola, Jeanne
    Lane, Adam
    Conard, Lee Ann E.
    Mullins, Tanya Lilliane Kowalczyk
    BLOOD, 2020, 136